Neumora Therapeutics, Inc. (NMRA)
0.3672
-0.02
(-5.43%)
USD |
NASDAQ |
Oct 30, 16:00
0.3673
0.00 (0.00%)
After-Hours: 20:00
Neumora Therapeutics Cash and Short Term Investments (Annual) : 182.53M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 182.53M |
| December 31, 2024 | 308.79M |
| December 31, 2023 | 453.98M |
| December 31, 2022 | 371.93M |
| Date | Value |
|---|---|
| December 31, 2021 | 409.37M |
| December 31, 2020 | 192.10M |
| December 31, 2019 | 0.00 |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| EyePoint, Inc. | 306.09M |
| Context Therapeutics, Inc. | 66.00M |
| LENZ Therapeutics, Inc. | 292.35M |
| BioAge Labs, Inc. | 281.10M |
| ANI Pharmaceuticals, Inc. | 294.75M |